RNAinsight®: A Year in Review
Since October 2019, +RNAinsight has revolutionized germline genetic testing for hereditary cancer and has provided clinically actionable results to many patients and families who may have otherwise received a negative or inconclusive result from DNA-only testing. Here are some highlights from the first year.